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ABSTRACT
This study at a major financial services corporation sought to investigate the association of
arthritis with on-the-job productivity, also termed “presenteeism.” Using a modified version
of the Work Limitations Questionnaire (WLQ) incorporated into a Health Risk Appraisal
(HRA), 17,685 employees responded to the survey in 2002. Of the 16,651 respondents meeting
inclusion criteria, 2,469 (14.8%) reported having arthritis, and 986 (39.9% of those with arthri-
tis) also reported that they were under medical care and/or taking medication for arthritis.
Employees with arthritis were older, predominantly female, and reported a higher number
of comorbidities. Although all four domains of the WLQ (physical, time, mental, and output)
were impacted by arthritis, the greatest productivity effect, as expected, was on physical work
tasks. Health risks also play a role in the relationship between arthritis and presenteeism,
with high-risk individuals reporting 7%–10% additional loss of productivity compared to low-
risk individuals. In addition, those who reported receiving medication and/or treatment for
arthritis had a 2.5% excess productivity loss independently attributed to their arthritis, which
equals approximately $1,250 per employee per year, or $5.4 million to the corporation. This
arthritis effect was discernible in those with low and moderate levels of health risk, but was
not as evident in those with high health risks; in that group, health-associated decrements in
productivity were much larger. Arthritis is associated with work productivity loss. Disease
management programs should focus on pain management and arthritis-associated health risks
and comorbidities in order to significantly decrease arthritis-related losses in on-the-job pro-
ductivity. (Disease Management 2006;9:131–143)
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INTRODUCTION
ARTHRITIS and other rheumatic conditionsare the leading cause of disability among
adults in the United States.1 In 2001, an esti-
mated 33% of adults, about 70 million Ameri-
cans, had arthritis or chronic joint symptoms.2
The costs of arthritis are expected to increase
with the aging US population. The prevalence
of arthritis increases with age and is greater in
women than in men.3 The medical and lost pro-
ductivity costs of arthritis and other rheumatic
conditions in 1997 were estimated at $86 bil-
lion.4 Arthritis and other rheumatic conditions
have a substantial impact on health, as dem-
onstrated by health-related quality of life mea-
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sures.5 Those with arthritis more commonly re-
port fair or poor health, more days when phys-
ical health and/or mental health are not good,
more unhealthy days, and more days of recent
activity limitations.5
Osteoarthritis affects 21 million adults and is
the most common form of arthritis in the
United States; rheumatoid arthritis affects
about 2.1 million adult Americans.3,6 Os-
teoarthritis causes a significant burden in lost
productivity in the workplace, often leading to
early retirement, and is second only to cardio-
vascular disease as the leading cause of work
disability.7,8 Obesity is a significant risk factor
for osteoarthritis. Research has shown that
overweight and obesity precedes the develop-
ment of osteoarthritis rather than being a con-
sequence due to arthritis-related inactivity.9,10
Factors associated with disability in people
with osteoarthritis include pain, psychosocial
factors such as depressive symptoms, muscle
weakness, poor aerobic exercise capacity, and
severity of the disease on x-ray. Job-related
arthritis is associated with workplace injury,
with arthritis developing years later. Some
states consider nonoccupational arthritis that is
exacerbated by work to be job-related. The dif-
ficulties in determining what is work-related,
work-exacerbated, or just reported in the work-
ers compensation system makes these figures
difficult to interpret. Yelin et al reported on the
probability of work disability in patients with
rheumatoid arthritis. As expected, as the dis-
ease worsened and its duration lengthened, the
probability of disability increased.11–14
Leigh estimated job-related costs of osteo-
arthritis in the United States to be $3.41–$13.23
billion per year (1994 dollars).15 About 51% of
the job-related arthritis costs are medical, and
49% are from lost productivity at work.15 A
more recent study by Ricci et al estimated the
lost productive time due to arthritis in the US
workforce to be $7.11 billion. A disproportion-
ate amount of this cost was due to workers who
had pain exacerbations or flare-ups.16
Arthritis is considered by many as an age-re-
lated disease that causes relatively minor dis-
comfort and pain. Yet, arthritis has serious eco-
nomic consequences because it is a common
chronic disease in the working population and
once workers develop this disease, it can affect
job productivity for the remainder of their ca-
reers. Limitations in the performance of simple
tasks due to pain can lead to permanent work
disability.17
For a nonfatal disabling disease such as
arthritis, the lifetime economic consequence of
disability and lost productivity may greatly ex-
ceed the healthcare costs. We have previously
reported on the impact of several medical con-
ditions, including arthritis, on worker produc-
tivity, also termed “presenteeism.”18 The pur-
pose of this study is to more thoroughly




The population in this study was employed
by one of the largest financial services compa-
nies in the United States, with employees lo-
cated in 29 states. Approximately 73,500 peo-
ple were employed, 70% of whom were female,
during the third quarter of 2002. The mean age
of the workforce was approximately 38 years.
The majority of employees performed clerical
jobs such as accounting, receiving/sorting fi-
nancial statements, customer service, and a va-
riety of other financial services tasks.
Health Risk Appraisal
In July 2002, a Health Risk Appraisal (HRA)
questionnaire was distributed to all employees
from the Corporate Medical Department. This
HRA was based on Healthier People, Version 4.0,
1991 (Carter Center of Emory University, At-
lanta, GA, 1991) and enhanced in cooperation
with the University of Michigan’s Health Man-
agement Research Center (UMHMRC; Ann Ar-
bor, MI). Each participant completing the HRA
received an individualized report summariz-
ing their health risks and suggestions for health
improvement directly from the UMHMRC. A
Mayo Clinic Self-Care book (retail value $16.95)
was provided to employees completing the
HRA.
In addition to asking employees about the
presence of biological and lifestyle health risk
factors, the HRA included the following ques-
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tion about the presence of several chronic dis-
eases: “Has your doctor ever told you that you
have had any of the following?” The list of
chronic conditions included seasonal allergies,
asthma, arthritis, back pain, cancer (any type),
depression, diabetes mellitus, heartburn, heart
disease, high cholesterol, hypertension, irrita-
ble bowel syndrome, kidney disease, meno-
pause, and osteoporosis. Additionally, respon-
dents were asked whether they were either
being treated by a physician or currently tak-
ing medications for those conditions for which
they reported “yes.” This study was conducted
in accordance with the University of Michi-
gan’s Institutional Review Board.
Worker productivity assessment
The 25-item self-administered Work Limita-
tions Questionnaire (WLQ) was developed and
validated to measure health-related decre-
ments in job-related productivity loss.19 It has
also been validated in a population of 230
workers with osteoarthritis to assess the impact
of osteoarthritis on worker productivity.20 The
WLQ measures four domains of on-the-job pro-
ductivity: physical work activities, time man-
agement, mental/interpersonal activities, and
overall output or productivity.
An eight-item brief version of the WLQ was
included in the HRA to assess the health-re-
lated impact of chronic medical conditions
such as arthritis on work performance.18,21
These questions evaluated the percentage of
time at work that an emotional or physical
problem interfered with one or more of the four
work domains. Employees were asked to base
their responses on their previous 2 weeks of
work and to rate any impairment as “All of the
Time (100%),” “Most of the Time,” “Half of the
Time (50%),” “Some of the Time,” “None of the
Time (0%)” or “Does Not Apply to My Job.”
For each item, scores of 0, 1, 2, 3, and 4 were
assigned to answers of “none of the time (0%),”
“some of the time,” “half of the time (50%),”
“most of the time,” and “all of the time (100%),”
respectively. An answer of “does not apply to
my job” was considered a missing answer.
The WLQ was scored as four subscales from
two questions related to each of the four do-
mains. An overall WLQ score was calculated
by averaging the four subscale scores. In this
way, the score has a range of 0 to 4, and each
score of 1 represents a 25% loss of self-reported
productivity. The percentage of productivity
loss associated with health risks was estimated
directly by multiplying the WLQ score by
25%.21 To study the odds of reporting any work
limitation in work domains or overall work, di-
chotomous scores (yes/no) for each subscale
and the overall work limitation were estab-
lished.
Short-term disability
All employees in this financial services cor-
poration are eligible to file short-term disabil-
ity (STD) claims. STD is managed initially by
the corporation and begins after 5 consecutive
workdays off and may continue for up to 6
months. All STD claims include diagnostic
codes (ICD-9 codes) in addition to the number
of days absent. Arthritis events are identified
by ICD-9 codes 710–719.9.
Statistical analysis
A multivariate, logistic regression model was
constructed to study the odds of reporting for
each WLQ subscale and overall work limita-
tion, with age, gender, health risks, and each
medical condition as independent variables. A
second multiple regression model was used to
calculate the percent productivity loss for each
group due to arthritis by controlling for de-
mographics, health risks, and the other health
conditions. This analysis utilized a generalized
linear model in SAS with a negative binomial
distribution. Then, the excess work loss was
calculated by subtracting each group’s percent
productivity loss from that of the reference
group (no arthritis). All analyses were con-
ducted using SAS 8.0 software (SAS Institute
Inc., Cary, NC).
RESULTS
In July 2002, 73,456 employees were sent an
HRA; of these, 17,685 were returned (24% re-
sponse rate). To meet the criteria for inclusion,
the respondent had to be listed in the corpora-
tion’s personnel database and have completed
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all the WLQ questions. As a result of these se-
lection criteria, 1,034 (1%) questionnaires were
excluded from the study, leaving a total of
16,651 respondents. The response rate is typi-
cal of those reported for HRAs in the research
literature.22,23
The average age of respondents included in
the study was 38.9 years and 76% were female.
A total of 2,469 (14.8%) responded “yes” to hav-
ing arthritis; among them, 986 (5.9%) of re-
spondents reported that they were under med-
ical care for and/or taking medication for
arthritis. Table 1 compares employees with and
without arthritis. Those who reported having
arthritis are further split into those who re-
ported receiving care and/or medication for
arthritis and those who did not. On average,
employees with arthritis were older (46.2 vs.
37.6 years) and more likely to be female (83%
vs. 75%) than those without arthritis. After ad-
justing for demographics and other risks and
conditions, obesity (Body Mass Index [BMI] 
30), using medication to relax, fair or poor per-
ception of health, high stress, and the presence
of cancer, diabetes, or heart disease were sta-
tistically significantly more common among
employees with arthritis compared to those
without. Of employees reporting arthritis, 39%
were obese (BMI  30), 25% reported the use
of medication to relax, 22% reported fair or
poor health, and 42% had high stress. Em-
ployees with arthritis were significantly more
likely to be in the high-risk group (5 health
risk factors) than employees without arthritis
(p  0.0001). The average number of health risk
factors for employees with arthritis was 3.06, in
comparison with 2.24 for employees without
arthritis (p  0.0001).
When dividing the employees with arthritis
into those who do and do not receive medical
care and/or medication for the condition, there
are also some significant differences. These two
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TABLE 1. DEMOGRAPHICS OF STUDY POPULATIONa
Arthritis Arthritis Arthritis
All, No arthritis, (all), (no care), (med/care),
N  16,651 N  14,182 N  2,469 N  1,483 N  986
Demographics
Female* 76% 75% 83% 81% 87%
Average age** 38.9 37.6 46.2 45.4 47.4
Health risks
High stress** 35% 34% 42% 40% 44%
Obese (BMI  30)** 27% 25% 39% 35% 44%
Physical activity  1/wk 29% 28% 34% 32% 37%
Life dissatisfaction 28% 27% 32% 32% 30%
High blood pressure 18% 16% 30% 27% 36%
Use medication to relax** 17% 15% 25% 21% 32%
Perception of health (fair or poor)* 16% 15% 22% 18% 27%
Job dissatisfaction 14% 14% 16% 16% 15%
High cholesterol*** 8% 7% 14% 12% 18%
Current smokers 10% 10% 11% 11% 11%
Safety belt usage  90% 11% 11% 11% 11% 10%
Alcoholic drinks  14/wk 2% 2% 2% 2% 2%
Overall risk status**
0–2 risks 59% 62% 44% 48% 39%
3–4 risks 26% 25% 32% 31% 34%
5 risks 15% 13% 23% 20% 28%
Average number of risks** 2.36 2.24 3.06 2.86 3.36
aRisk analyses controlled for demographics, other risks, and other conditions.
*p  0.05 significant difference between no arthritis, arthritis no-care, and arthritis med/care groups.
**p  0.05 significant difference between no arthritis and arthritis group. Arthritis no-care and arthritis med/care
groups are not significantly different from each other.
***p  0.05 significant difference between no arthritis and arthritis med/care group. Arthritis no-care group also
significantly different from arthritis med/care group.
Med/care, under medical care for and/or taking medication for arthritis; BMI, Body Mass Index; wk, week.
groups are significantly different in the percent-
age of women (81% in no-care group, 87% in
med/care group), in perceiving their health as
fair or poor (18% in no-care group, 27% in
med/care group), and in having high cholesterol
(12% in no-care group, 18% in med/care group).
Participants had an opportunity to report 15
different health conditions on the HRA, one of
which was arthritis. Table 2 shows the percent-
ages of these conditions by the different study
populations. Similar to the number of health
risks, the number of other health conditions in
employees with arthritis was 1.49, in comparison
with 0.69 for employees without arthritis (p 
0.0001). After controlling for demographics,
health risks, and other health conditions, em-
ployees with arthritis who received medication
and/or medical care had significantly greater in-
cidence of the following health conditions com-
pared to employees without arthritis: seasonal
allergy, asthma, back pain, depression, heart
burn (acid reflux), high cholesterol, menopause,
and osteoporosis. Furthermore, the med/care
arthritis group had significantly more other con-
ditions that required medication or medical care
(2.24 vs. 0.98 for no-care group and 0.69 for those
without arthritis). Sixty-one percent of the
med/care arthritis group reported having one or
more other conditions, compared to 27% of the
no-care group (p  0.05).
The prevalence of arthritis in employees in
different age groups is shown in Figure 1. For
employees under age 40, the prevalence of
arthritis is less than 10%, whereas it exceeds
40% for employees age 60–64. For all age cate-
gories combined, 40% of employees reporting
they had been diagnosed with arthritis were ei-
ther under medical care and/or taking med-
ication for their arthritis (6% of employees in
the med/care group out of 14.8% of employees
reporting an arthritis diagnosis).
Work limitations
The impact of arthritis on work limitation is
summarized in Figure 2, which shows the re-
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TABLE 2. HEALTH CONDITIONS OF STUDY POPULATIONa
Arthritis Arthritis Arthritis
All, No arthritis, (all), (no care), (med/care),
N  16,651 N  14,182 N  2,469 N  1,483 N  986
Health conditions that require
medication or medical care
Seasonal allergy*** 22% 21% 30% 21% 43%
Asthma*** 5% 5% 8% 5% 13%
Back pain*** 7% 5% 17% 6% 34%
Cancer 2% 1% 3% 2% 4%
Depression** 9% 8% 15% 11% 20%
Diabetes 3% 3% 5% 4% 6%
Heart burn (acid reflex)*** 9% 7% 17% 11% 27%
Heart disease 1% 1% 3% 2% 4%
High cholesterol* 8% 7% 15% 10% 21%
High blood pressure 11% 9% 21% 17% 28%
Irritable bowel syndrome 3% 2% 5% 3% 8%
Kidney disease 0% 0% 1% 0% 1%
Menopause*** 8% 6% 19% 13% 28%
Osteoporosis*** 1% 1% 5% 2% 8%
Average number of health conditions*** 0.81 0.69 1.49 0.98 2.24
Having one or more other conditions*** 21% 18% 40% 27% 61%
aAnalyses controlled for demographics, overall risk status, and other conditions.
*p  0.05 significant difference between no arthritis, arthritis no-care, and arthritis med/care groups.
**p  0.05 significant difference between no arthritis and arthritis group. Arthritis no-care and arthritis med/care
groups are not significantly different from each other.
***p  0.05 significant difference between no arthritis and arthritis med/care group. Arthritis no-care group also
significantly different from arthritis med/care group.
Med/care, under medical care for and/or taking medication for arthritis.
sults of multiple logistic regression controlling
for demographics, other health conditions, and
health risks. The odds of reporting any work
impairment for each of the four WLQ domains
and overall are reported in Figure 2. The two
arthritis groups (no-care and med/care
groups) were compared with employees who
did not report having arthritis as well as with
each other, controlling for age, gender, health
risks, and other health conditions. Compared
to employees without arthritis, the group of
employees with arthritis but not receiving care
or medication for the condition had signifi-
cantly higher odds of reporting a work limita-
tion for all four domains (Odds Ratio [OR] for
time, 1.23; physical, 1.25; mental, 1.21; output,
1.14) and overall (OR  1.28). The arthritis
group receiving medication and/or care was
significantly different from employees without
arthritis for both the physical (OR  1.53) and
output (OR  1.24) domains, as well as any
limitation overall (OR  1.42). Furthermore,
the arthritis med/care group had significantly
higher odds of reporting a physical work lim-
itation compared to the arthritis group receiv-
ing no medication or care (1.53 arthritis
med/care vs. 1.25 arthritis no-care).
Table 3 shows the WLQ scores and the cor-
responding percent productivity loss, which is
calculated by multiplying the WLQ score by
25%. The WLQ and, subsequently, the percent
productivity loss increases from the no arthri-
tis group (score of 0.629) to the arthritis no-care
group (0.653) to the arthritis med/care group
(0.730). In each group of employees (no arthri-
tis, arthritis no-care, and arthritis med/care),
those with more health risks also have more
productivity loss.
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FIG. 1. Prevalence of self-reported arthritis and age for employees with arthritis, with and without medication
and/or medical care.
FIG. 2. Odds of having work limitations associated with arthritis and with/or without medication or under med-
ical care (controlling for demographics, health risks, and other health conditions). *p  0.01 between no arthritis and
arthritis no-care groups. **p  0.01 comparing both arthritis no-care and arthritis med/care groups to no arthritis
group. ***p  0.01 All three groups are significantly different from each other.
Figure 3 shows the impact of health risks on
worker productivity among those with arthri-
tis. Comparisons were made across the three
study groups by health risk category. Results
are shown as percentage of productivity loss,
which is calculated by multiplying the WLQ
score by 25%.
While arthritis is certainly associated with
increased on-the-job productivity loss, health
risks also play a role. All comparison groups
except the low-risk arthritis no-care group
have significantly greater work loss com-
pared to the low-risk group of employees
without arthritis. Health risks are clearly an
important factor to consider when examining
presenteeism. One important finding is that
employees with arthritis (whether or not 
they are being treated for it) who maintain
low health risks have lower productivity 
loss compared to those without arthritis but
in the medium- or high-risk category. The
highest reported productivity losses are in
the two arthritis groups with high health
risks (22.4% in no-care group, 22.0% in
med/care group). The non-arthritis group
with high risks also has high levels of re-
ported productivity loss (21.7%), compared
to those with low risks.
After controlling for demographics, risk
level, and other health conditions, the overall
productivity loss of employees in the non-
arthritis, no-care, and receiving care groups are
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FIG. 3. Percent productivity loss associated with arthritis and health risk status. All except low-risk arthritis no-care
group are p  0.001 compared to low-risk no arthritis group.
TABLE 3. WLQ SCORE AND PERCENT PRODUCTIVITY LOSS FOR EMPLOYEES
WITH AND WITHOUT ARTHRITIS BY HEALTH RISK CATEGORY*
Risk Percentage productivity loss
Arthritis status category WLQ score (WLQ score  25%)
No arthritis** All 0.629 15.7%
0–2 risks 0.448 11.2%
3–4 risks 0.668 16.7%
5 risks 0.866 21.7%
Arthritis no care** All 0.653 16.3%
0–2 risks 0.458 11.4%
3–4 risks 0.703 17.6%
5 risks 0.897 22.4%
Arthritis med/care** All 0.730 18.2%
0–2 risks 0.587 14.7%
3–4 risks 0.764 19.1%
5 risks 0.880 22.0%
*p  0.001 compared to low-risk no arthritis group, except low-risk arthritis no-care group.
**p  0.001 arthritis med/care overall is significantly different from no arthritis and arthritis no-care groups.
WLQ, Work Limitations Questionnaire; med/care, under medical care for and/or taking medication for 
arthritis.
15.7%, 16.3%, and 18.2%, respectively. Results
showed that the arthritis no-care group has
similar work loss compared to the non-arthri-
tis group (16.3% compared to 15.7%). The
group of employees with arthritis who re-
ported receiving medical treatment or medica-
tion had a work loss of 18.2%. Subtracting the
15.7% productivity loss of the reference group
(no arthritis) from the 18.2% productivity loss
of the arthritis med/care group results in an
excess productivity loss of 2.5% compared to
the non-arthritic employees.
DISCUSSION
Employees who report having medically
treated arthritis were found to be older, had
more comorbidities, and had a greater number
of health risk factors than other employees. The
prevalence of arthritis increases with age. In all,
14.8% of employees report having arthritis. Ap-
proximately 40% of these employees report the
use of medication or medical care for their
arthritis. This percentage is fairly consistent for
all age groups until approximately age 55,
when 46% of arthritis employees receive care.
Among the oldest age group in our study
(60–64 years), 50% of employees with arthritis
report receiving care and/or medication for the
condition (Fig. 1). These data suggest that there
is an opportunity for disease management pro-
grams to educate employees about receiving
appropriate treatment for their arthritis.
Even after controlling for demographics,
health risks, and other health conditions, em-
ployees with arthritis who were not receiving
treatment had significantly increased risk for
limitations in all four WLQ domains, as well as
any limitation overall. Arthritic employees
who were receiving treatment had an increased
risk of limitation in their ability to do physical
aspects of the job and in their output compared
to those without arthritis. Arthritic employees
receiving medication or care were significantly
more likely to have a physical work limitation
compared to arthritic employees who did not
receive care.
Interestingly, those who reported having
arthritis but not receiving care had significantly
higher odds of work limitations in the time and
mental/interpersonal domains of the WLQ
compared to employees without arthritis. The
group of employees with arthritis who received
treatment did not show significantly higher
odds of limitation in these two WLQ domains.
It may be that medication and/or other forms
of medical treatment for arthritis help employ-
ees to be more productive in certain aspects of
their job compared to employees not receiving
care for their arthritis. In one of the domains—
the physical aspect—employees receiving
treatment still have significantly higher odds of
a work limitation compared to employees not
receiving treatment. Those who do seek med-
ication and/or treatment may have a more se-
vere form of arthritis which, not surprisingly,
significantly impacts their ability to perform
physical tasks. Given the prevalence data pre-
sented by age, younger employees may feel
that they are “too young” to seek treatment for
their arthritis. As noted, it wasn’t until age 60
that at least 50% of arthritic employees received
care or medication for the condition. There may
be an opportunity for the corporate medical de-
partment to educate employees on available
treatments for arthritis and to encourage em-
ployees to seek appropriate care.
As expected, our study demonstrated that
the greatest on-the-job productivity effect of
arthritis was on physical work tasks, where
those with arthritis (med/care) were 1.5 times
as likely to self-report productivity problems as
workers without arthritis (Fig. 2). The risk for
having problems with work output and the
overall measure of work limitation were also
significantly elevated, though as would be ex-
pected, less so than for physical problems. The
pattern is consistent with expected physical
limitations that are the hallmark of this condi-
tion.
In their validation study of 230 employees
with osteoarthritis, the authors of the WLQ
found that the Physical Demand scale scores
varied with the level of arthritis pain, joint stiff-
ness, and functional limitations.20 Physical De-
mand scores were affected by the severity of
osteoarthritis and comorbid conditions. The
Time Management Scale was associated with
the severity of osteoarthritis. The Mental-Inter-
personal Demand Scale was related to arthritis
pain and stiffness, but there was no significant
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difference between controls and patients with
osteoarthritis. The Output Demands scale was
associated with the amount of pain and stiff-
ness, but not with the degree of functional lim-
itations.
Health risks also play a role in the relation-
ship between arthritis and work impairment.
As can be seen in Figure 3, those with arthritis
(both no-care and med/care groups) who
maintain a low level of health risk (0–2 risk fac-
tors) have a smaller percentage of on-the-job
work loss than those without arthritis, but who
are medium (3–4 risks) or high (5 risks) risk.
The literature has shown that worksite health
promotion programs can be successful in help-
ing employees to reduce their health risks.24–26
Disease management programs combined with
health promotion programs could possibly re-
sult in improved work performance, even
among those with chronic conditions such as
arthritis.
Employees who reported receiving treat-
ment for their arthritis also reported a greater
number of comorbidities than their fellow em-
ployees. Some of these are not surprising, such
as back pain and osteoporosis. Twenty percent
of employees with arthritis who were receiv-
ing treatment or medication for their condition
also reported depression. This compares with
8% of employees without arthritis and 11% of
employees with arthritis not receiving care.
One study of arthritis and depression found
that the two conditions often occur together.27
Furthermore, these investigators found that in
an older population, successful treatment of
depression also decreased pain and improved
functional status and quality of life among sub-
jects.27 Disease management programs aimed
at helping employees deal with their arthritis
should be cognizant of the comorbidities which
they may have.
Employees with arthritis who are receiving
medication or treatment for their condition
have 2.5% excess work loss compared to em-
ployees without arthritis. Employees with
arthritis who did not receive care had a simi-
lar level of work loss compared to employees
without arthritis, even after controlling for
health risk level, other health conditions, and
demographics. The 2.5% excess productivity
loss found here is similar to results found in a
previous study in this same population.21 In
that cross-sectional study of one-time HRA par-
ticipants, each additional risk factor that em-
ployees had was associated with a 2.4% loss in
self-reported productivity. A second study of
productivity change associated with health risk
change found that adding or subtracting health
risks over time resulted in a 1.9% change in self-
reported productivity loss.28 These three re-
sults combined lead to the conclusion that each
additional risk factor or health condition is as-
sociated with approximately 2% more produc-
tivity loss compared to low-risk employees
without health conditions. It may be advanta-
geous to elevate health conditions to the same
status as health risks traditionally examined in
HRAs. In this instance, one health condition—
arthritis—shows approximately the same level
of work loss as the average health risk (such as
smoking or obesity).
The criteria for identifying workers with
arthritis in our study was similar to other pop-
ulation-based investigations that have at-
tempted to identify all workers with arthritis
requiring medical treatment.1,29 Alternative
“objective” measures of osteoarthritis, such as
range of motion or radiographic changes do not
correlate well with functional or clinically-im-
portant impacts.30,31 The prevalence of self-re-
ported arthritis in this study was similar to
other surveys.32 These studies have demon-
strated an increased prevalence of arthritis with
age, female gender and more comorbidities.
However, symptomatic arthritis is not confined
to the elderly; it has a substantial impact on
working populations as well.33
Other studies also have demonstrated the
negative impact of arthritis on work produc-
tivity. Muchmore et al34 analyzed health
claims, disability payments, and productivity
data from a sample of 36,776 workers, and
found an average of over $350 excess costs for
work absence in those with self-reported, med-
ically treated arthritis. However, unlike the
current study, they did not demonstrate a sig-
nificant impact on on-the-job productivity,
likely due to the insensitivity of the single ques-
tion measure employed. Similar findings were
noted in the study by Kessler et al,29 where one
third of those with arthritis had some self-re-
ported limitation in work function, with an
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odds ratio of 1.7. However, these prior studies
did not specify the actual type of work limita-
tions encountered due to these conditions. Al-
though the incidence of arthritis increases with
age, and presumably the severity increases
with age as well, the percentage of those with
arthritis who had work limitations was not age
related in the current study. This is most likely
due to the healthy worker effect, where those
with more severe or progressive disease leave
the workplace, often through earlier retire-
ment.17,35
Based on the current study, the cost of lost
workplace productivity is estimated at $1,250
per employee with arthritis per year ($50,000
salary 2.5% lost productivity). Assuming that
this study sample is representative of the en-
tire study population, 5.9% of all employees
have arthritis for which they receive treatment
or medication. The total cost of their lost work-
place productivity is estimated at $5.4 million
per year ($1,250 per employee per year  5.9%
of employees  73,500 employees).
We also examined STD claims for this same
employee population in 2002 utilizing ICD-9
codes 710–719.9 and identified 218 employees
with at least one STD event for arthritis. In
2002, the corporation experienced a total of 236
arthritis-related STD events accounting for
9,197 STD workdays lost, or 3.0% of all events
and 3.5% of all STD workdays lost. The eco-
nomic cost of arthritis-related STD workdays
lost to the company, assuming an average em-
ployee salary and benefits of $50,000 and 250
work days per year, is approximately $1.8 mil-
lion ($50,000/250  9,197  $1.8M).
These results demonstrate that for a financial
services company with a relatively young and
predominantly female population, the major
impact of arthritis is on lost worker productiv-
ity—presenteeism—rather than STD absen-
teeism. However, the dollar estimates calcu-
lated here are likely an overstatement since it
is known that a greater percentage of the HRA
participants in this company are female and
older compared to HRA nonparticipants.
Muchmore et al34 reported on the prevalence
and costs related to arthritis and associated
joint disorder (AJD) among 230,000 employees
of several companies in the United States. The
overall prevalence of arthritis and AJD was
15.5% for a population that was 56.6% female,
with a mean age of 42.7 years. These authors
noted that employees with AJDs had signifi-
cantly higher healthcare and prescription drug,
absenteeism, STD, long-term disability, and
worker compensation costs, which totaled
$1,802. Productivity was 4% lower for workers
with AJDs. However, productivity data was
limited to a subset of employees in this study
who were predominantly hourly workers in a
“manufacturing-like environment.” Productiv-
ity was measured as units processed per hour
and annually. No further details were provided
by the authors. Our study measured produc-
tivity for a variety of workers at all job levels
in this financial services corporation.
A limitation of our study is that it is cross-
sectional. We are unable to determine the life-
time impact of arthritis in this population, since
we do not have the date of onset of the disease.
In addition, we are unable to determine the ef-
fect of severity of disease or its actual functional
limitation on worker productivity. The HRA
questionnaire was distributed in July and
asked about work limitations during the pre-
vious 2-week period. Therefore, we believe that
impairment may be underestimated, since this
is the summer season in the United States and
many arthritis patients perceive improvement
in their arthritis symptoms with warmer tem-
peratures.36
The results found here suggest that those
who have arthritis but do not receive medica-
tion or care have similar work loss compared
to those without arthritis. As suggested earlier,
those who do not take medication or receive
care for their arthritis may have a less severe
form of the condition compared to those who
do receive care or medication. Companies
would benefit from including questions on
HRAs that identify those who receive medica-
tion or care for their self-reported health con-
ditions as a surrogate measure for the severity
of a given condition.
We noted earlier that this group of HRA par-
ticipants is more likely to be female and older
compared to the rest of this company’s em-
ployee population. Furthermore, the group of
employees who report receiving care or med-
ication for their arthritis is also more likely to
be female and older compared to employees
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with arthritis who do not receive care or med-
ication. This may be due to the fact that women
may be more likely to seek medical attention
than men. While the analyses controlled for de-
mographics, the extrapolation of the economic
cost of productivity loss did not and thus may
be overestimated.
The significantly reduced work-related pro-
ductivity associated with arthritis is under-
standable for physically demanding jobs. In
general, financial services jobs are not physi-
cally demanding except for the ubiquitous use
of computers. Skills such as data input and typ-
ing clearly can be more difficult for an em-
ployee with significant arthritis. The finding
that less than half of employees with arthritis
are either under medical care and/or taking
medication may indicate opportunities for sig-
nificant improvement in the management of
this chronic medical condition.
The implications of this study include sup-
port for the early identification of limitations in
work function and appropriate treatment for
arthritis, before the onset significantly impacts
worker productivity.17 Self-management and
behavioral disease management programs for
arthritis can be successful and have a signifi-
cant impact on function.37,38 The results also
provide great impetus for employers and
healthcare providers to address obesity, phys-
ical inactivity, and other health risks as signif-
icant contributing factors to the decrements in
on-the-job productivity of employees with
arthritis.39,40 An HRA that includes the WLQ
is a valuable tool for disease management pro-
gram administrators to use to evaluate the im-
pact of a program on an employer’s produc-
tivity, absenteeism, and STD costs. These costs
are significant and are often not included in a
disease management program’s return-on-in-
vestment calculation.
This study provides a unique source of infor-
mation on the impact of the most common form
of arthritis on workplace productivity. Previ-
ously published studies of work function impli-
cations of arthritis have generally focused on
rheumatoid arthritis.41 One limitation of the
present study is that the data are specific to one
employer. However, rather than manual labor,
the types of jobs for this employer include cleri-
cal as well as administrative roles, which are typ-
ical of a majority of the current US workforce.42
Arthritis is a relatively common, treatable
chronic disease in the employed population,
which has a significant impact on worker pro-
ductivity. Disease management programs pres-
ent an opportunity to enhance the quality of
life of those patients and, at the same time, po-
tentially limit the significant losses in on-the-
job productivity for employers.43
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